RPRX logo

Royalty Pharma (RPRX) Long term liabilities

Annual long term liabilities:

$6.63B+$490.55M(+7.99%)
December 31, 2024

Summary

  • As of today (May 21, 2025), RPRX annual total long term liabilities is $6.63 billion, with the most recent change of +$490.55 million (+7.99%) on December 31, 2024.
  • During the last 3 years, RPRX annual long term liabilities has fallen by -$469.34 million (-6.61%).
  • RPRX annual long term liabilities is now -6.61% below its all-time high of $7.10 billion, reached on December 31, 2021.

Performance

RPRX Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

quarterly long term liabilities:

$6.64B+$10.01M(+0.15%)
March 31, 2025

Summary

  • As of today (May 21, 2025), RPRX quarterly total long term liabilities is $6.64 billion, with the most recent change of +$10.01 million (+0.15%) on March 31, 2025.
  • Over the past year, RPRX quarterly long term liabilities has increased by +$494.15 million (+8.04%).
  • RPRX quarterly long term liabilities is now -13.01% below its all-time high of $7.63 billion, reached on June 30, 2024.

Performance

RPRX quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

RPRX Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.0%+8.0%
3 y3 years-6.6%-6.5%
5 y5 years+10.9%+14.9%

RPRX Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.6%+8.3%-13.0%+8.4%
5 y5-year-6.6%+13.9%-13.0%+14.9%
alltimeall time-6.6%+13.9%-13.0%+14.9%

RPRX Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$6.64B(+0.2%)
Dec 2024
$6.63B(+8.0%)
$6.63B(+0.2%)
Sep 2024
-
$6.62B(-13.3%)
Jun 2024
-
$7.63B(+24.2%)
Mar 2024
-
$6.14B(+0.1%)
Dec 2023
$6.14B(+0.2%)
$6.14B(-0.1%)
Sep 2023
-
$6.14B(+0.1%)
Jun 2023
-
$6.14B(+0.0%)
Mar 2023
-
$6.14B(+0.2%)
Dec 2022
$6.12B
$6.12B(-0.1%)
Sep 2022
-
$6.12B(-14.3%)
DateAnnualQuarterly
Jun 2022
-
$7.15B(+0.7%)
Mar 2022
-
$7.10B(+0.1%)
Dec 2021
$7.10B(+22.0%)
$7.10B(+0.1%)
Sep 2021
-
$7.09B(+21.7%)
Jun 2021
-
$5.83B(+0.1%)
Mar 2021
-
$5.82B(+0.1%)
Dec 2020
$5.82B(-2.7%)
$5.82B(-1.8%)
Sep 2020
-
$5.92B(+1.4%)
Jun 2020
-
$5.84B(+1.1%)
Mar 2020
-
$5.77B(-3.3%)
Dec 2019
$5.98B(-4.2%)
$5.98B
Dec 2018
$6.24B
-

FAQ

  • What is Royalty Pharma annual total long term liabilities?
  • What is the all time high annual long term liabilities for Royalty Pharma?
  • What is Royalty Pharma annual long term liabilities year-on-year change?
  • What is Royalty Pharma quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Royalty Pharma?
  • What is Royalty Pharma quarterly long term liabilities year-on-year change?

What is Royalty Pharma annual total long term liabilities?

The current annual long term liabilities of RPRX is $6.63B

What is the all time high annual long term liabilities for Royalty Pharma?

Royalty Pharma all-time high annual total long term liabilities is $7.10B

What is Royalty Pharma annual long term liabilities year-on-year change?

Over the past year, RPRX annual total long term liabilities has changed by +$490.55M (+7.99%)

What is Royalty Pharma quarterly total long term liabilities?

The current quarterly long term liabilities of RPRX is $6.64B

What is the all time high quarterly long term liabilities for Royalty Pharma?

Royalty Pharma all-time high quarterly total long term liabilities is $7.63B

What is Royalty Pharma quarterly long term liabilities year-on-year change?

Over the past year, RPRX quarterly total long term liabilities has changed by +$494.15M (+8.04%)
On this page